HAYWARD, Calif., April 10 /PRNewswire/ -- Metabolex, Inc. today announced that Harold E. Van Wart, Ph.D., president and CEO of Metabolex, will speak on a panel at the Biotechnology Industry Organization (BIO) 2006 Annual International Convention, which is taking place April 9-12 at the McCormick Place Convention Center in Chicago.
The panel, “Back to Life! Successful Restarts and Rebounds,” is scheduled for Wednesday, April 12, from 2:00 - 3:30 p.m. Central Time during a BIO 2006 Break-Out Session in the “Finance” track. The panel will cover how to successfully plan and implement a turn-around strategy for a life sciences company.
About Metabolex
Metabolex is a privately held biotechnology company dedicated to the discovery and development of novel therapeutics to transform the treatment of diabetes and related metabolic disorders. Metabolex has drawn on its deep understanding of diabetes to create the largest database of genes involved in diabetes and to build a rich pipeline of product candidates and drug discovery targets. The company’s clinical program is focused on developing next- generation insulin sensitizers that lower blood glucose without the serious safety and tolerability issues associated with currently marketed products. For additional information about Metabolex and its development pipeline, visit www.metabolex.com.
Metabolex, Inc.
CONTACT: Mark Bagnall of Metabolex, Inc., +1-510-293-8800, ormbagnall@metabolex.com; or Daryl Messinger of WeissComm Partners,+1-415-999-2361, or daryl@weisscommpartners.com, for Metabolex, Inc.
Web site: http://www.metabolex.com/
